Clinical Research Directory
Browse clinical research sites, groups, and studies.
Low-osmolar Water Soluble Contrast Agent in Management of Adhesive Small Bowel Obstruction
Sponsor: Queen Savang Vadhana Memorial Hospital, Thailand
Summary
Adhesive small bowel obstruction (ASBO) is a condition that is commonly found in patients with history of abdominal surgery. The management for such condition can be controversial. In terms of conservative treatment, recent studies have shown conflicting outcomes on whether water soluble contrast would provide benefit in reducing number of patients needed for surgery. In addition, there are a limited number of literature that investigates the role of low-osmolar contrast in reducing operative need in patients diagnosed with ASBO. The objective of this study is to compare the operative rate of patient diagnosed with ASBO between patients who were treated with low osmolar water soluble contrast (Iohexol) and patients who were treated traditionally.
Official title: Randomized Controlled Trial of Low-osmolar Water Soluble Contrast Agent in Management of Adhesive Small Bowel Obstruction
Key Details
Gender
All
Age Range
18 Years - 90 Years
Study Type
INTERVENTIONAL
Enrollment
66
Start Date
2024-06
Completion Date
2025-07
Last Updated
2024-04-04
Healthy Volunteers
No
Interventions
Low osmolar contrast
100 mL of 350 mg omnipaque will be administered via nasogastric tube
Sterile water
100 mL of sterile water will be administered via nasogastric tube